These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 18388031

  • 1. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.
    Lee TM, Su SF, Hwang JJ, Tseng CD, Chen MF, Lee YT, Wang SS.
    Atherosclerosis; 2001 Oct; 158(2):471-6. PubMed ID: 11583728
    [Abstract] [Full Text] [Related]

  • 4. The effects of cilostazol on exercise-induced ischaemia-reperfusion injury in patients with peripheral arterial disease.
    O'Donnell ME, Badger SA, Sharif MA, Makar RR, McEneny J, Young IS, Lee B, Soong CV.
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):326-35. PubMed ID: 19112032
    [Abstract] [Full Text] [Related]

  • 5. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE.
    Am J Med; 2000 Nov; 109(7):523-30. PubMed ID: 11063952
    [Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.
    Thompson PD, Zimet R, Forbes WP, Zhang P.
    Am J Cardiol; 2002 Dec 15; 90(12):1314-9. PubMed ID: 12480040
    [Abstract] [Full Text] [Related]

  • 8. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Dec 15; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 9. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease.
    O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV.
    J Vasc Surg; 2009 May 15; 49(5):1226-34. PubMed ID: 19217745
    [Abstract] [Full Text] [Related]

  • 10. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr 15; 18(100):56-9. PubMed ID: 19585717
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of cilostazol and other therapies for intermittent claudication.
    Dawson DL.
    Am J Cardiol; 2001 Jun 28; 87(12A):19D-27D. PubMed ID: 11434896
    [Abstract] [Full Text] [Related]

  • 12. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication.
    Wang T, Elam MB, Forbes WP, Zhong J, Nakajima K.
    Atherosclerosis; 2003 Dec 28; 171(2):337-42. PubMed ID: 14644405
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 28; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 14. Cilostazol: a novel treatment option in intermittent claudication.
    Cariski AT.
    Int J Clin Pract Suppl; 2001 Apr 28; (119):11-8. PubMed ID: 11355274
    [Abstract] [Full Text] [Related]

  • 15. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL, DeMaioribus CA, Hagino RT, Light JT, Bradley DV, Britt KE, Charles BE.
    Am J Surg; 1999 Aug 28; 178(2):141-6. PubMed ID: 10487267
    [Abstract] [Full Text] [Related]

  • 16. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
    Weismantel D.
    J Fam Pract; 2001 Feb 28; 50(2):181. PubMed ID: 11219570
    [No Abstract] [Full Text] [Related]

  • 17. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE, Bortey EB, Forbes WP.
    Arch Intern Med; 1999 Sep 27; 159(17):2041-50. PubMed ID: 10510990
    [Abstract] [Full Text] [Related]

  • 18. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL, Cutler BS, Meissner MH, Strandness DE.
    Circulation; 1998 Aug 18; 98(7):678-86. PubMed ID: 9715861
    [Abstract] [Full Text] [Related]

  • 19. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC, Moher D, Barber GG.
    CMAJ; 1996 Oct 15; 155(8):1053-9. PubMed ID: 8873633
    [Abstract] [Full Text] [Related]

  • 20. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Oct 15; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.